Effects of Two Herbal Dietary Supplements on Lipid Metabolism in Moderate Hypercholesterolemia and Hypertriglyceridemia
Phase 1
Completed
- Conditions
- HypercholesterolemiaHypertriglyceridemia
- Interventions
- Dietary Supplement: PlaceboDietary Supplement: VAL070-ADietary Supplement: VAL070-B
- First Posted Date
- 2016-12-12
- Last Posted Date
- 2018-07-05
- Lead Sponsor
- Valbiotis
- Target Recruit Count
- 40
- Registration Number
- NCT02989753
- Locations
- 🇫🇷
Biofortis Mérieux NutriSciences Clinical Investigation Center, Saint Herblain, France
Effect of Totum-63, Active Ingredient of Valedia, on Glucose and Lipid Homeostasis on Subjects With Prediabetes
Phase 2
Completed
- Conditions
- PrediabetesInsulin ResistanceType 2 DiabetesHypertriglyceridemiaDiseaseObesity
- Interventions
- Dietary Supplement: Totum-63Dietary Supplement: Placebo
- First Posted Date
- 2016-08-16
- Last Posted Date
- 2020-10-05
- Lead Sponsor
- Valbiotis
- Target Recruit Count
- 66
- Registration Number
- NCT02868177
- Locations
- 🇫🇷
Institut Pasteur de Lille, Lille, France
🇫🇷Biofortis Mérieux NutriSciences Clinical Investigation Center, Saint Herblain, France
🇷🇸Clinical center of Kragujevac, / Poseidon CRO, Kragujevac, Serbia
Tolerance Study of the Dietary Supplement Valedia
Phase 1
Completed
- Conditions
- Overweight
- Interventions
- Dietary Supplement: Valedia
- First Posted Date
- 2016-06-06
- Last Posted Date
- 2016-08-09
- Lead Sponsor
- Valbiotis
- Target Recruit Count
- 14
- Registration Number
- NCT02790489
- Locations
- 🇫🇷
Centre d'Investigation Clinique, Clermont-Ferrand, France
© Copyright 2025. All Rights Reserved by MedPath